[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1977

Curettage-Electrodesiccation Treatment of Basal Cell Carcinomas

Author Affiliations

From the Department of Dermatology, New York University School of Medicine, and the Oncology Section, Skin and Cancer Unit, New York University Medical Center, New York.

Arch Dermatol. 1977;113(4):439-443. doi:10.1001/archderm.1977.01640040047006
Abstract

• Cure rates after treatment of basal cell carcinomas with curettage-electrodesiccation were compared among three groups: group A, 597 lesions treated in the Skin and Cancer Unit in 1958 to 1962; group B, 91 lesions treated in the Skin and Cancer Unit in 1970; and group C, 210 lesions treated in private practice in 1962 to 1973. The following were the five-year cumulative recurrence rates: group A, 18.8%; group B, 9.6%; and group C, 5.7%. In all three groups, there were high recurrence rates for tumors treated on the nose, paranasal areas, and forehead.

Few complications occurred after curettage-electrodesiccation with the exception of hypertrophic scars. The cosmetic results following curettage-electrodesiccation improved with time.

Curettage-electrodesiccation, when performed by experienced physicians, is a very useful modality for the treatment of basal cell carcinomas, with cure rates of over 90%, satisfactory cosmetic results, and few significant complications.

(Arch Dermatol 113:439-443, 1977)

×